‘And Now She’s Dead.’ Series and the Femicide of Marijke Meiresonne
The new series “And Now She’s Dead.”, created by Phara de Aguirre and Nahid Shaikh, has resonated deeply with audiences, particularly in light of a personal tragedy experienced by de Aguirre. The series explores themes of violence against women, and its impact was heightened when de Aguirre discovered her niece, Marijke Meiresonne, was the victim of a femicide in Zwijndrecht, Belgium.
Personal Connection to a Real-Life Tragedy
Phara de Aguirre, 64, shared her shock and grief after learning that her niece, Marijke Meiresonne, was the woman murdered in Zwijndrecht. De Aguirre recounted hearing reports of the murder on the radio throughout the day, only realizing the victim was family when she received a message in the evening according to HLN.
The Series and its Impact
“And Now She’s Dead.” is described as a powerful and impactful series, a “sledgehammer” of a production as reported by De Morgen. The series’ exploration of violence against women took on a new layer of meaning for de Aguirre following the death of her niece. The initial reports of the murder in Zwijndrecht surfaced approximately two years ago, when a woman was found seriously injured as noted by Humo.
Femicide in Belgium
The case highlights the ongoing issue of femicide, the intentional killing of women due to the fact that of their gender. The tragedy underscores the importance of raising awareness and addressing violence against women.
Worth a look
- Top 14: Stade Toulousain Crushes UBB 48-12
- How Argonne Uses AI to Solve Major Biology Challenges
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- Stock futures fall as investors weigh AI safety concerns, oil gains: Live updates (newsylist.com)